Clovis Oncology applies to begin trials for targeted cancer therapy candidate
BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) has filed two Investigational New Drug applications to the U.S. Food and Drug […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
CSU Spur nears completion near Stock Show complex
DENVER — According to the Merriam-Webster dictionary, the word “spur” could mean “a goad to action, a stimulus.” It also…
Bankrupt Clovis faces delisting from Nasdaq
BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS), which filed for Chapter 11 bankruptcy protection Dec. 11, has received a delisting…
Clovis Oncology files Chapter 11, agrees to sell a drug asset
BOULDER and WILMINGTON, Delaware — Boulder-based Clovis Oncology Inc. (Nasdaq: CLVS) filed for Chapter 11 bankruptcy protection Sunday. Its filing…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…